CHADS2 versus CHA2DS2-VASc score in assessing the stroke and thromboembolism risk stratification in patients with atrial fibrillation: a systematic review and meta-analysis.
Lists
Only you see this
Abstract
The C-statistic suggests a similar clinical utility of the CHADS2 and CHA2DS2-VASc scores in predicting stroke and thromboembolism, but CHA2DS2- VASc has the important advantage of identifying extremely low-risk patients with atrial fibrillation, as well as classifying a lower proportion of patients as moderate risk.
BibTeX
@inproceedings{chen2013chads,
author = {Jiayuan Chen and Aidong Zhang and Hongyan Lu and Jun Guo and Feifei Wang and Zicheng Li},
title = {{CHADS2 versus CHA2DS2-VASc score in assessing the stroke and thromboembolism risk stratification in patients with atrial fibrillation: a systematic review and meta-analysis.}},
booktitle = {PubMed},
year = {2013},
doi = {10.3969/j.issn.1671-5411.2013.03.004},
}Loading related content...